Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial

NCT04693468 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

111

Enrollment

OTHER

Sponsor class

Conditions

Advanced Malignant Solid Neoplasm
Metastatic Malignant Solid Neoplasm
Recurrent Malignant Solid Neoplasm

Interventions

DRUG: Axitinib
DRUG: Crizotinib
DRUG: Palbociclib Isethionate
DRUG: Talazoparib Tosylate

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]